Metabolomic and Gut Microbial Biomarkers of Smoking Cessation Treatment in Long-term Drug Therapy: a Randomized Controlled Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 3, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

June 30, 2026

Conditions
Substance Use Disorder (SUD)Alcohol Use Disorder (AUD)Nicotine Addiction
Interventions
BEHAVIORAL

6-weeks CBT smoking cessation programme

Held in the therapeutic community, the intervention will employ principles of cognitive-behavioural therapy (CBT) coupled with personalized recommendations for nicotine replacement. The Austrian Health Insurance standard for therapy will be guiding the program's content, which is tailored for inpatient clients. Specifically, the following interventions based on CBT techniques will be applied in the weekly group sessions consisting of 10 to 15 participants: Psychoeducation including information on tobacco addiction, health risks, advice on relapse prevention and the handling of craving, motivation building, behavioural observation.

BEHAVIORAL

Long-term drug therapy within a therapeutic community

The standard treatment within the 'Grüner Kreis' therapeutic community - which all participants will receive - consists of group therapy (once a week), individual psychotherapy (once a week), counselling by social workers, psychiatric consultations, as well as sport-, art- and work-therapy. Daily life is organized according to principles of therapeutic community-based addiction treatment.

Trial Locations (3)

1020

Sigmund Freud Private University Vienna, Vienna

8036

Medical University Graz, Graz

8350

Grüner Kreis Organization Johnsdorf Facility, Johnsdorf Brunn

All Listed Sponsors
collaborator

Medical University of Graz

OTHER

lead

Sigmund Freud PrivatUniversitat

OTHER

NCT06803706 - Metabolomic and Gut Microbial Biomarkers of Smoking Cessation Treatment in Long-term Drug Therapy: a Randomized Controlled Trial | Biotech Hunter | Biotech Hunter